The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat
Abstract
Background—: Probiotics are extensively used to promote gastrointestinal health, and emerging evidence suggests that their beneficial properties can extend beyond the local environment of the gut. Here, we determined whether oral probiotic administration can alter the progression of postinfarction heart failure. Methods and Results—: Rats were subjected to 6 weeks of sustained coronary artery occlusion and administered the probiotic Lactobacillus rhamnosus GR-1 or placebo in the drinking water ad libitum. Culture and 16s rRNA sequencing showed no evidence of GR-1 colonization or a significant shift in the composition of the cecal microbiome. However, animals administered GR-1 exhibited a significant attenuation of left ventricular hypertrophy based on tissue weight assessment and gene expression of atrial natriuretic peptide. Moreover, these animals demonstrated improved hemodynamic parameters reflecting both improved systolic and diastolic left ventricular function. Serial echocardiography revealed significantly improved left ventricular parameters throughout the 6-week follow-up period including a marked preservation of left ventricular ejection fraction and fractional shortening. Beneficial effects of GR-1 were still evident in those animals in which GR-1 was withdrawn at 4 weeks, suggesting persistence of the GR-1 effects after cessation of therapy. Investigation of mechanisms showed a significant increase in the leptin:adiponectin plasma concentration ratio in rats subjected to coronary ligation, which was abrogated by GR-1. Metabonomic analysis showed differences between sham control and coronary artery ligated hearts particularly with respect to preservation of myocardial taurine levels. Conclusions—: The study suggests that probiotics offer promise as a potential therapy for the attenuation of heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, administration of Lactobacillus rhamnosus GR-1 in rodents improved systolic and diastolic left ventricular function following coronary artery ligation170.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [170]
In the citing paper
“In a small comparative GWAS study involving n=1,892 subjects with relatively preserved renal function, it was suggested that genetic variant play a relatively weak role in determining TMAO levels204.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [204]
In the citing paper
“It has also been linked to weight reduction, prevention of ischemia-reperfusion injury, and attenuation of cardiac hypertrophy and post-infarction heart failure in rodents[403,418,419]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [418]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T. L., Garrity, G. M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,873
Lozupone, C., Hamady, M., Kelley, S. T., & Knight, R. D. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01996-06 · Cited by 2,717
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
Swann, J. R., Want, E. J., Geier, F. M., Spagou, K., Wilson, I. D., Sidaway, J. E., Nicholson, J. K., & Holmes, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006734107 · Cited by 726
Self-citationMicrobiota restoration: natural and supplemented recovery of human microbial communities
Reid, G., Younes, J. A., van der Mei, H. C., Gloor, G. B., Knight, R. D., & Busscher, H. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2473 · Cited by 607
Self-citationAdipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 578
Myocardial Failure in Cats Associated with Low Plasma Taurine: a Reversible Cardiomyopathy
Pion, P. D., Kittleson, M. D., Rogers, Q. R., & Morris, J. G. (1987) · Science · doi:10.1126/science.3616607 · Cited by 500
Microbes and the gut‐brain axis
Bercik, P., Collins, S. M., & Verdu, E. F. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01906.x · Cited by 417
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.
Verbrugge, F. H., Dupont, M., Steels, P., Grieten, L., Malbrain, M., Tang, W. H. W., & Mullens, W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.070 · Cited by 380
Cited by
Sorted by citations
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Dietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789
Kalogeris, T. J., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive physiology · doi:10.1002/cphy.c160006 · Cited by 856
The microbiome of the urinary tract—a role beyond infection
Whiteside, S. A., RAZVI, H. A., Davé, S., Reid, G., & Burton, J. P. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.361 · Cited by 657
Self-citationIntestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 524
Human milk microbiota profiles in relation to birthing method, gestation and infant gender
Urbaniak, C., Angelini, M., Gloor, G. B., & Reid, G. (2016) · Microbiome · doi:10.1186/s40168-015-0145-y · Cited by 487
Self-citationTrøseid, M., Andersen, G. Ø., Broch, K., & Hov, J. R. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102649 · Cited by 416
Microbiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedLoss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair
Tang, T. W. H., Chen, H.-C., Chen, C.-Y., Yen, C. Y. T., Lin, C.-J., Prajnamitra, R. P., Chen, L.-L., Ruan, S.-C., Lin, J.-H., Lin, P.-J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035235 · Cited by 348
Tang, W. H. W., Wang, Z., Shrestha, K., Borowski, A. G., Wu, Y., Troughton, R. W., Klein, A. L., & Hazen, S. L. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.11.006 · Cited by 325
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616713 · Cited by 323
TMAO: how gut microbiota contributes to heart failure
Zhang, Y., Wang, Y., Ke, B., & Du, J. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.007 · Cited by 311
Probiotics: definition, scope and mechanisms of action
Reid, G. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.12.001 · Cited by 273
Self-citationZhang, Y., Zhang, S., Li, B., Luo, Y., Gong, Y., Jin, X., Zhang, J., Zhou, Y., Zhuo, X., Wang, Z., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab114 · Cited by 279
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
Kamo, T., Akazawa, H., Suda, W., Saga-Kamo, A., Shimizu, Y., Yagi, H., Liu, Q., Nomura, S., Naito, A. T., Takeda, N., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174099 · Cited by 268
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., Harun-Or-Rashid, M., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 272
Inclusion of Fermented Foods in Food Guides around the World
Chilton, S., Burton, J. P., & Reid, G. (2015) · Nutrients · doi:10.3390/nu7010390 · Cited by 262
Self-citationThe gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
Zhen, J., Zhou, Z., He, M., Han, H.-X., Lv, E., Wen, P., Liu, X., Wang, Y., Cai, X., Tian, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085041 · Cited by 248
Dedkova, E. N., & Blatter, L. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00260 · Cited by 227
Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats
Gómez‐Guzmán, M., Toral, M., Romero, M., Jiménez, R., Galindo, P., Sánchez, M., Zarzuelo-Romero, M. J., Olivares, M. M., Gálvez, J., & Duarte, J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500290 · Cited by 216
Breast milk microbiota: A review of the factors that influence composition
Zimmermann, P., & Curtis, N. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.01.023 · Cited by 205
Liang, D., Leung, R. K., Guan, W., & Au, W. W. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0230-4 · Cited by 206
The gut microbiota and its interactions with cardiovascular disease
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q., & Cai, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13524 · Cited by 196
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186
Costanza, A. C., Moscavitch, S. D., Faria Neto, H. C. C., & Mesquita, E. T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.034 · Cited by 182
The influence of the human microbiome and probiotics on cardiovascular health
Ettinger, G., MacDonald, K., Reid, G., & Burton, J. P. (2014) · Gut Microbes · doi:10.4161/19490976.2014.983775 · Cited by 180
Self-citationInteraction between gut microbiome and cardiovascular disease
Peng, J., Xiao, X., Hu, M., & Zhang, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.063 · Cited by 180
Benson, T. W., Conrad, K. A., Li, X. S., Wang, Z., Helsley, R. N., Schugar, R. C., Coughlin, T. M., Wadding-Lee, C., Fleifil, S., Russell, H., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.060573 · Cited by 166
Pharmacological basis and new insights of resveratrol action in the cardiovascular system
Cheng, C. K., Luo, J., Lau, C. W., Chen, Z., Tian, X. Y., & Huang, Y. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14801 · Cited by 166
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Jin, L., Shi, X., Yang, J., Zhao, Y., Xue, L., Xu, L., & Cai, J. (2020) · Protein & Cell · doi:10.1007/s13238-020-00785-9 · Cited by 143
Antihypertensive Effects of Probiotics
Robles‐Vera, I., Toral, M., Romero, M., Jiménez, R., Sánchez, M., Pérez‐Vizcaíno, F., & Duarte, J. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0723-4 · Cited by 138
Gut microbiota in various childhood disorders: Implication and indications
Saeed, N. K., Al‐Beltagi, M., Bediwy, A. S., El-Sawaf, Y., & Toema, O. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i18.1875 · Cited by 153
Hanafi, N. I., Mohamed, A. S., Kadir, S. H. S. A., & Othman, M. H. D. (2018) · Biomolecules · doi:10.3390/biom8040159 · Cited by 140
Motevaseli, E., Shirzad, ., Akrami, S. M., Mousavi, A., Mirsalehian, A., & Modarressi, M. H. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.057521-0 · Cited by 134
Nemet, I., Li, X. S., Haghikia, A., Li, L., Wilcox, J. D., Romano, K. A., Buffa, J. A., Witkowski, M., Demuth, I., König, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad333 · Cited by 131
Zhao, J., Qi, Z., Cheng, W., Dai, Q., Wei, Z., Guo, M., Chen, F., Qiao, S., Hu, J., Wang, J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad023 · Cited by 126
Virk, M. S., Virk, M. A., He, Y., Tufail, T., Gul, M., Qayum, A., Rehman, A., Rashid, A., Ekumah, J., Han, X., et al. (2024) · Nutrients · doi:10.3390/nu16040546 · Cited by 144
Metabolic network modeling of microbial communities
Biggs, M. B., Medlock, G. L., Kolling, G. L., & Papin, J. A. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1308 · Cited by 124
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 132
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., Li, Y., Lv, S., & Zhang, J. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/5164298 · Cited by 119
Liu, Z., Liu, H., Zhou, H., Zhan, Q., Lai, W., Zeng, Q., Ren, H., & Xu, D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01687 · Cited by 115
MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1
Liu, X., Xu, Y., Deng, Y., & Li, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489185 · Cited by 106
Cole‐Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000307 · Cited by 101
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Vasquez, E. C., Pereira, T. D. M. C., Peotta, V. A., Baldo, M. P., & Campos‐Toimil, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3086270 · Cited by 99
Liu, X., Deng, Y., Xu, Y., Jin, W., & Li, H. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.03.018 · Cited by 95
Zhang, L., Deng, M., Lu, A., Chen, Y., Chen, Y., Wu, C.-Y., Tan, Z., Boini, K. M., Yang, T., Zhu, Q., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14684 · Cited by 94
Microbial applications for sustainable space exploration beyond low Earth orbit
Koehle, A. P., Brumwell, S. L., Seto, E. P., Lynch, A. M., & Urbaniak, C. (2023) · npj Microgravity · doi:10.1038/s41526-023-00285-0 · Cited by 110
Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences
Serino, M., Blasco-Baque, V., Nicolas, S., & Burcelin, R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0540-1 · Cited by 93
Zhao, X., Zhong, X., Liu, X., Wang, X., & Gao, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.693412 · Cited by 91
Anto, L., & Blesso, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108991 · Cited by 90
Chen, X., Li, H., Hu, X., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000330 · Cited by 84
The changes of gut microbiota after acute myocardial infarction in rats
Wu, Z., Li, S., Chen, H., Song, J.-X., Gao, Y., Zhang, F., & Cao, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180717 · Cited by 84
The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
Forkosh, E., & Ilan, Y. (2019) · Open Heart · doi:10.1136/openhrt-2018-000993 · Cited by 86
The Implication of the Gut Microbiome in Heart Failure
Lupu, V. V., Răileanu, A. A., Mihai, C. M., Morariu, I. D., Lupu, A., Stârcea, I. M., Frăsinariu, O. E., Mocanu, A., Dragan, F., & Fotea, S. (2023) · Cells · doi:10.3390/cells12081158 · Cited by 89
Lacticaseibacillus rhamnosus GR-1, a.k.a. Lactobacillus rhamnosus GR-1: Past and Future Perspectives
Petrova, M., Reid, G., & ter Haar, J. A. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.010 · Cited by 80
Self-citationHuang, K., Liu, Y., Tang, H., Qiu, M., Li, C., Duan, C., Wang, C., Yang, J., & Zhou, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00107 · Cited by 77
Gao, J., Yan, K.-T., Wang, J.-X., Dou, J., Wang, J., Ren, M., Ma, J., Zhang, X., & Liu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-59235-5 · Cited by 76
Karim, A., Muhammad, T., Shah, I., Khan, J., & Qaisar, R. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.06.006 · Cited by 74
Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
Probiotics: Protecting Our Health from the Gut
Varela-Trinidad, G. U., Domínguez-Díaz, C., Solórzano-Castanedo, K., Íñiguez-Gutiérrez, L., Hernández-Flores, T. D. J., & Fafutis‐Morris, M. (2022) · Microorganisms · doi:10.3390/microorganisms10071428 · Cited by 80
The Role of the Gut Microbiota in Coronary Heart Disease
Liu, H., Zhuang, J., Tang, P., Li, J., Xiong, X., & Deng, H. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00892-2 · Cited by 76
The central role of the gut in intensive care
Corriero, A., Gadaleta, R. M., Puntillo, F., Inchingolo, F., Moschetta, A., & Brienza, N. (2022) · Critical Care · doi:10.1186/s13054-022-04259-8 · Cited by 78
Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure
Kamo, T., Akazawa, H., Suzuki, J.-I., & Komuro, I. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0028 · Cited by 73
The gut microbiome and heart failure: A better gut for a better heart
Branchereau, M., Burcelin, R., & Heymes, C. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09519-7 · Cited by 74
The development of probiotics for women’s health
Reid, G. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2016-0733 · Cited by 69
Self-citationTousoulis, D., Guzik, T. J., Padró, T., Duncker, D. J., Luca, G. D., Eringa, E. C., Vavlukis, M., Antonopoulos, A. S., Katsimichas, T., Cenko, E., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac057 · Cited by 67
Li, L., Zhong, S.-J., Hu, S.-Y., Cheng, B., Qiu, H., & Hu, Z. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02202-5 · Cited by 63
Myocardial infarction and gut microbiota: An incidental connection
Vahed, S. Z., Barzegari, A., Tamayo, M. Z., Letourneur, D., & Pavon‐Djavid, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.008 · Cited by 65
Gut Dysbiosis and Heart Failure: Navigating the Universe Within
Madan, S., & Mehra, M. R. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1792 · Cited by 62
Pan, Z., Hu, Y., Huang, Z., Han, N., Li, Y., Zhuang, X., Yin, J., Peng, H., Gao, Q., Zhang, W., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2056-1 · Cited by 64
Lai, C., Tsai, C., Kuo, W., Ho, T., Day, C. H., Pai, P., Chung, L.-C., Huang, C.-C., Wang, H.-F., Liao, P., et al. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.14769 · Cited by 62
Self-citationAdipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
Senesi, P., Luzi, L., & Terruzzi, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218372 · Cited by 65
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 64
Gut microbial metabolites and its impact on human health
Rahman, S. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0809 · Cited by 70
Akhoundzadeh, K., Vakili, A., Shadnoush, M., & Sadeghzadeh, J. (2018) · Europe PMC (PubMed Central) · Cited by 59
Klippel, B. F., Duemke, L. B., Leal, M. A. S., Friques, A. G. F., Dantas, E. M., Dalvi, R. D. F., Gava, A. L., Pereira, T. D. M. C., de Andrade, T. U., Meyrelles, S. S., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00211 · Cited by 58
Update on gut microbiota in cardiovascular diseases
Qian, B., Zhang, K., Li, Y., & Sun, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1059349 · Cited by 63
Fu, F., Zhao, K., Li, J., Xu, J., Zhang, Y., Liu, C., Yang, W., Gao, C., Li, J., Zhang, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17927 · Cited by 57
Zhong, S., Guo, H., Wang, H., Xing, D., Lu, T., Yang, J., & Wang, C. (2020) · Bioscience Reports · doi:10.1042/bsr20200040 · Cited by 57
Forty-five-year evolution of probiotic therapy
Puebla-Barragan, S., & Reid, G. (2019) · Microbial Cell · doi:10.15698/mic2019.04.673 · Cited by 63
Self-citationGut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
Huang, Z., Mei, X., Jiang, Y., Chen, T., & Zhou, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.803744 · Cited by 54
Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
An, N., Zhang, G., Li, Y., Yuan, C., Yang, F., Zhang, L., Gao, Y., & Xing, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865353 · Cited by 56
Microbes Central to Human Reproduction
Reid, G., Brigidi, P., Burton, J. P., Contractor, N., Duncan, S. H., Fargier, E., Hill, C., Lebeer, S., Martín, R., McBain, A. J., et al. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12319 · Cited by 52
Self-citationAssociation between Bacterial Infection and Peripheral Vascular Disease: A Review
Wiśniewska, J., Ciecierski, M., Kędzia, A., & Budzyński, J. (2015) · International Journal of Angiology · doi:10.1055/s-0035-1547385 · Cited by 53
Čierniková, S., Mego, M., & Chovanec, M. (2021) · Cancers · doi:10.3390/cancers13040782 · Cited by 55
Cicero, A. F. G., Colletti, A., von Haehling, S., Vinereanu, D., Bielecka-Dabrowa, A. M., Sahebkar, A., Toth, P. P., Reiner, Ž., Wong, N. D., Mikhailidis, D. P., et al. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000049 · Cited by 53
Silva‐Cutini, M. A., de Almeida, S. A., do Nascimento, A. M., Abreu, G. R., Bissoli, N. S., Lenz, D., Endringer, D. C., Brasil, G. A., de Lima, E. M., Biancardi, V. C., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.006 · Cited by 50
Ferulic acid increases intestinal Lactobacillus and improves cardiac function in TAC mice
Liu, Z., Ma, Z., Zhang, H., Summah, B. S., Liu, H., An, D., Zhan, Q., Lai, W., Zeng, Q., Ren, H., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109482 · Cited by 48
The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide
Al-Rubaye, H., Perfetti, G., & Kaski, J.-C. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.06.005 · Cited by 43
Probiotics in obstetrics and gynaecology
Griffin, C. J. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12303 · Cited by 47
The Gut–Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction
Rivera, K., González, L., Bravo, L., Manjarres, L., & Andía, M. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212465 · Cited by 51
Targeting the Microbiome in Heart Failure
Zabell, A., & Tang, W. H. W. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0528-4 · Cited by 48
Prisco, S. Z., Eklund, M., Moutsoglou, D., Prisco, A. R., Khoruts, A., Weir, E. K., Thenappan, T., & Prins, K. W. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022722 · Cited by 47
Gut Microbiome-Based Management of Patients With Heart Failure
Mamic, P., Snyder, M. P., & Tang, W. H. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.045 · Cited by 51
Gut microbiota in heart failure and related interventions
Chen, A., Zhang, J., & Zhang, Y. (2023) · iMeta · doi:10.1002/imt2.125 · Cited by 48
Metadata
- Authors
- Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P., Haist, J. V., Rajapurohitam, V., Sidaway, J. E., Martin, G., Gloor, G. B., Swann, J. R., Reid, G., & Karmazyn, M.
- Affiliations
- Western University (CA)
- ORCID
- Venue
- Circulation: Heart Failure
- Published
- 2014-05
- Volume
- 7
- Issue
- 3
- Pages
- 491-499
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2154813987
- Cited by
- 329
- References
- 38
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 34 · 2023: 45 · 2022: 46 · 2021: 44 · 2020: 23 · 2019: 21 · 2018: 17 · 2017: 17 · 2016: 12 · 2015: 14 · 2014: 8
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- World Health Organization
- Canadian Institutes of Health Research (MOP62764)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- probiotics, Lactobacillus rhamnosus GR-1, myocardial infarction, post-infarction heart failure, left ventricular hypertrophy, atrial natriuretic peptide, leptin/adiponectin ratio, taurine, gut-heart axis, coronary artery occlusion, left ventricular function, cecal microbiota
- MeSH terms
- Administration, Oral, Animals, Disease Models, Animal, Cardiomegaly, Heart Failure, Heart Ventricles, Hemodynamics, Male, Myocardial Infarction, Rats, Sprague-Dawley, Disease Progression, Probiotics, Rats, Coronary Occlusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
